MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Change in Accured Expenses came in at $8.7 million in Q4 2025, down 6.95% YoY from $9.4 million in Q4 2024, and up 185.39% on a QoQ basis from -$10.2 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Change in Accured Expenses data on file, last reported at $8.7 million in Q4 2025.

  • Quarterly Change in Accured Expenses fell 6.95% year-over-year to $8.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 131.59% YoY) and the FY2025 annual result came in at $4.4 million, up 131.59% from the prior year.
  • Change in Accured Expenses rose to $8.7 million in Q4 2025, from -$10.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $13.5 million in Q4 2023 to a low of -$24.2 million in Q1 2024.
  • A 5-year average of -$313105.3 and a median of $1.6 million in 2024 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 11956.52% — and 2025, when it tumbled 748.48%.
  • Tracing MGTX's Change in Accured Expenses over 5 years: stood at $5.0 million in 2021, then plunged by 51.98% to $2.4 million in 2022, then soared by 460.92% to $13.5 million in 2023, then plunged by 30.62% to $9.4 million in 2024, then dropped by 6.95% to $8.7 million in 2025.
  • The last three Change in Accured Expenses figures came in at $8.7 million (Q4 2025), -$10.2 million (Q3 2025), and $9.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 21.99 Mn
Sep 30, 2025 40.15 Mn
Jun 30, 2025 -9.01 Mn
Mar 31, 2025 -3.59 Mn
Dec 31, 2024 9.39 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 -697,000.00
Mar 31, 2024 -24.23 Mn
Dec 31, 2023 12.56 Mn
Sep 30, 2023 3.32 Mn
Jun 30, 2023 -5.77 Mn
Mar 31, 2023 -11.47 Mn
Dec 31, 2022 11.02 Mn
Sep 30, 2022 2.65 Mn
Jun 30, 2022 2.77 Mn
Mar 31, 2022 -3.83 Mn
Dec 31, 2021 10.13 Mn
Sep 30, 2021 3.04 Mn
Jun 30, 2021 23,000.00
Mar 31, 2021 -5.07 Mn